Marie Sandstrom
Overview
Explore the profile of Marie Sandstrom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Earp J, Mehrotra N, Peters K, Fiorentino R, Griebel D, Lee S, et al.
J Pediatr Gastroenterol Nutr
. 2016 Nov;
65(3):272-277.
PMID: 27875488
Objectives: Food and Drug Administration approval of proton-pump inhibitors for infantile gastroesophageal reflux disease has been limited by intrapatient variability in the clinical assessment of gastroesophageal reflux disease. For children...
2.
Dahl M, Bergsten C, Hammarberg A, Sandstrom M, Strinnholm M
Lakartidningen
. 2014 Sep;
111(32-33):1296-8.
PMID: 25221821
No abstract available.
3.
Bostrom E, Ohrn F, Hanze E, Sandstrom M, Martin P, Wahlby-Hamren U
J Clin Pharmacol
. 2014 Jun;
54(12):1337-46.
PMID: 24895144
Fostamatinib is an oral spleen tyrosine kinase (SYK) inhibitor which has been evaluated as a potential treatment for rheumatoid arthritis (RA). Treatment with fostamatinib has been associated with an increase...
4.
Sandstrom M, Davidson G, Tolia V, Sullivan J, Langstrom G, Lundborg P, et al.
Clin Ther
. 2012 Jul;
34(8):1828-38.
PMID: 22832034
Background: Several oral proton pump inhibitors (PPIs) are currently approved for use in pediatric patients in North America and Europe. However, when use of oral therapy is not possible or...
5.
Zhang S, Sandstrom M, Ahlsen M, Ivarsson N, Zhu H, Ma J, et al.
Exp Physiol
. 2010 May;
95(8):892-8.
PMID: 20472648
2-Methoxyoestradiol (2-ME) is an oestrogen derivative that inhibits superoxide dismutase (which converts superoxide anions to H(2)O(2)). Since reactive oxygen species have been implicated in glucose transport, we determined the effect...
6.
Friberg L, Sandstrom M, Karlsson M
Invest New Drugs
. 2009 Aug;
28(6):744-53.
PMID: 19711011
Aim: To investigate the potential of a model for chemotherapy-induced myelosuppression to predict the full time-course of myelosuppression in patients based on rat data. Methods: White blood cell counts were...
7.
Hansson E, Wallin J, Lindman H, Sandstrom M, Karlsson M, Friberg L
Cancer Chemother Pharmacol
. 2009 Aug;
65(5):839-48.
PMID: 19680655
Purpose: A previously developed semi-physiological model of chemotherapy-induced myelosuppression has shown consistent system-related parameter and inter-individual variability (IIV) estimates across drugs. A requirement for dose individualization to be useful is...
8.
Lannergard A, Viberg A, Cars O, Karlsson M, Sandstrom M, Larsson A
Scand J Infect Dis
. 2009 Jul;
41(9):663-71.
PMID: 19626562
The accuracy of using body temperature, serum amyloid A (SAA), C-reactive protein (CRP) and interleukin-6 (IL-6) in the work-up for early or late step-down therapy after an initial course of...
9.
Nielsen E, Sandstrom M, Honore P, Ewald U, Friberg L
Clin Pharmacokinet
. 2009 Jun;
48(4):253-63.
PMID: 19492870
Background And Objective: Preterm and term newborn infants show wide interindividual variability (IIV) in pharmacokinetic parameters of gentamicin. More extensive knowledge and use of predictive covariates could lead to faster...
10.
Omari T, Lundborg P, Sandstrom M, Bondarov P, Fjellman M, Haslam R, et al.
J Pediatr
. 2009 Apr;
155(2):222-8.
PMID: 19394048
Objective: To characterize the pharmacodynamics and systemic exposure of esomeprazole in 26 preterm infants and term neonates with symptoms of gastroesophageal reflux and pathologic acid exposure. Study Design: Enrolled patients...